DexCom (DXCM)
(Delayed Data from NSDQ)
$70.43 USD
-1.49 (-2.07%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $70.35 -0.08 (-0.11%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for DexCom, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 541.50 | 341.20 | 154.70 | 493.60 | 101.10 |
Depreciation/Amortization & Depletion | 186.00 | 155.90 | 102.00 | 67.10 | 48.70 |
Net Change from Assets/Liabilities | 3.20 | 26.70 | -132.00 | -20.80 | 6.10 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 17.80 | 145.70 | 317.80 | -64.30 | 158.60 |
Net Cash From Operating Activities | 748.50 | 669.50 | 442.50 | 475.60 | 314.50 |
Property & Equipment | 2,710.80 | -364.80 | -389.20 | -199.00 | -180.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -3.90 | -30.20 | 0.00 | 0.00 |
Investments | -3,200.40 | -138.50 | 193.20 | -807.70 | -835.20 |
Other Investing Activities | -17.60 | -14.30 | 10.10 | -11.30 | 0.00 |
Net Cash from Investing Activities | -507.20 | -521.50 | -216.10 | -1,018.00 | -1,015.20 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -662.10 | -535.20 | 20.30 | 15.30 | 11.90 |
Issuance (Repayment) of Debt | 443.30 | 0.00 | 0.00 | 906.20 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -99.80 | -17.30 | -9.90 | -9.40 | -1.20 |
Net Cash from Financing Activities | -318.60 | -552.50 | 10.40 | 912.10 | 10.70 |
Effect of Exchange Rate Changes | 1.50 | -5.80 | -1.40 | 2.10 | -0.70 |
Net Change In Cash & Equivalents | -75.80 | -410.30 | 235.40 | 371.80 | -690.70 |
Cash at Beginning of Period | 643.30 | 1,053.60 | 818.20 | 446.40 | 1,137.10 |
Cash at End of Period | 567.50 | 643.30 | 1,053.60 | 818.20 | 446.40 |
Diluted Net EPS | 1.30 | 0.82 | 0.39 | 1.27 | 0.28 |
Fiscal Year End for DexCom, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 289.90 | 146.40 | 541.50 | 285.20 | 164.50 |
Depreciation/Amortization & Depletion | 104.60 | 52.50 | 186.00 | 133.50 | 85.30 |
Net Change from Assets/Liabilities | 86.60 | 19.00 | 3.20 | 261.30 | 98.30 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.50 | -8.70 | 17.80 | -65.10 | -2.40 |
Net Cash From Operating Activities | 488.60 | 209.20 | 748.50 | 614.90 | 345.70 |
Property & Equipment | -123.00 | -56.90 | 2,710.80 | -184.10 | -133.70 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 12.00 | 129.40 | -3,200.40 | -719.50 | -592.90 |
Other Investing Activities | -3.10 | 2.30 | -17.60 | -18.50 | -16.00 |
Net Cash from Investing Activities | -114.10 | 74.80 | -507.20 | -922.10 | -742.60 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 13.40 | 13.40 | -662.10 | -162.10 | -176.40 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 443.30 | 580.10 | 1,230.60 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -10.10 | -8.70 | -99.80 | -104.70 | -103.50 |
Net Cash from Financing Activities | 3.30 | 4.70 | -318.60 | 313.30 | 950.70 |
Effect of Exchange Rate Changes | -4.80 | -3.80 | 1.50 | -4.60 | -1.10 |
Net Change In Cash & Equivalents | 373.00 | 284.90 | -75.80 | 1.50 | 552.70 |
Cash at Beginning of Period | 567.50 | 567.50 | 643.30 | 643.30 | 643.30 |
Cash at End of Period | 940.50 | 852.40 | 567.50 | 644.80 | 1,196.00 |
Diluted Net EPS | 0.35 | 0.36 | 0.61 | 0.29 | 0.28 |